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Tomas A. Block, MD,a Stefan Acosta, MD, PhD,b and Martin Björck, MD, PhD,c Stockholm, Malmö, and
Uppsala, Sweden
Background: Acute thromboembolic occlusion of the superior mesenteric artery (SMA) is associated with high mortality.
Recent advances in diagnostics and surgical techniques may affect outcome.
Methods: Through the Swedish Vascular Registry (Swedvasc), 121 open and 42 endovascular revascularizations of the
SMA at 28 hospitals during 1999 to 2006 were identified. Patient medical records were retrieved, and survival was
analyzed with multivariate Cox-regression analysis.
Results: The number of revascularizations of the SMA increased over time with 41 operations in 2006, compared to 10
in 1999. Endovascular approach increased sixfold by 2006 as compared to 1999. The endovascular group had thrombotic
occlusion (P< .001) and history of abdominal angina (P .042) more often, the open group had atrial fibrillation more
frequently (P .031). All the patients in the endovascular group, but only 34% after open surgery, underwent completion
control of the vascular reconstruction (P< .001). Bowel resection (P< .001) and short bowel syndrome (SBS; P .009)
occurred more frequently in the open group. SBS (hazard ratio [HR], 2.6; 95% confidence interval [CI], 1.3-5.0) and age
(HR, 1.03/year; 95% CI, 1.00-1.06) were independently associated with increased long-term mortality. Thirty-day and
1-year mortality rates were 42% vs 28% (P  .03) and 58% vs 39% (P  .02), for open and endovascular surgery,
respectively. Long-term survival after endovascular treatment was better than after open surgery (log-rank, P  .02).
Conclusion: The results after endovascular and open surgical revascularization of acute SMA occlusion were favorable, in
particular among the endovascularly treated patients. Group differences need to be confirmed in a randomized trial.
(J Vasc Surg 2010;52:959-66.)Acute thromboembolic occlusion of the superior mes-
enteric artery (SMA) is associated with poor prognosis.1-6
With the advancement of radiologic imaging, early detec-
tion is feasible, which may result in a more planned tech-
nique for achieving intestinal revascularization.7,8 Hence, it
is likely that more patients may be treated in present times,
and that the development of endovascular options offers a
possibility to improve clinical outcome.9-15 However, pro-
spective studies are difficult to carry out, due to the low
incidence and emergency presentation of these patients. In
a previous study, data from the Swedish vascular registry
(Swedvasc) from 1987 to 1998 was analyzed to study the
outcome in patients undergoing intestinal revasculariza-
tion, almost exclusively by open surgical technique.16 A
renewed search from 1999 to 2006 in Swedvasc was per-
formed to assess the influence of radiologic imaging and
endovascular treatment in a large patient cohort. The pur-
pose of the present study was to analyze time-trends and
patient-related and management-related factors for out-
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PATIENTS AND METHODS
Swedvasc was started in 1987 and is a nationwide registry
for open and endovascular vascular surgerywith high reported
validity.17-20 We identified 174 revascularizations performed
on the indication of acute intestinal ischemia during the pe-
riod from 1999 to 2006. Vascular procedures are registered
regardless whether they are open or endovascular. They are
entered in accordance with “intention-to-treat,” ie, both suc-
cessful and failed interventions are registered. Patients are
usually registered during the hospitalization period for the
surgery or endovascular intervention, preferably immediately
after the operation or at discharge/death. Variables in Swed-
vasc are registered prospectively, patient and procedural data
at operation and clinical outcome after 1 month and 1 year.
Registry data was supplemented by retrospective analysis of
patient medical records from 28 surgical departments. Long-
term mortality data was obtained by cross-matching with the
national population registry in September 2009 using the
personal identity codes. Patients with symptoms of previous
chronic mesenteric ischemia were included if they presented
with an acute onset of intestinal ischemia. Elevenpatientswere
excluded due to misclassification. The remaining 163 proce-
dures and 161 patients were included in this study.
Hypertension was defined as blood pressure 140/90
mm Hg or medication for hypertension. Ischemic heart
disease (IHD) was defined as angina pectoris or previous
myocardial infarction. Cerebrovascular disease (CVD) was
defined as previous stroke or transient ischemic attack.
Renal insufficiency was defined as a creatinine level 150
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sudden (instantaneous, within minutes), acute (within 1
hour), or insidious (more than 1 hour). The clinical triad of
acute embolic occlusion of the SMA was defined as: pain
out of proportion to abdominal signs, possible source of
embolus (such as atrial fibrillation), and bowel emptying
(diarrhea and/or vomiting). Chronic mesenteric ischemia
was defined as postprandial abdominal pain with weight
loss and/or chronic diarrhea. Patient’s delay was defined as
the time delay from onset of symptoms to hospital admis-
sion, and doctor’s delay was defined as the time from
hospital admission to start of the operation. Total delay was
patient’s  doctor’s delay. Short bowel syndrome (SBS)
was defined as need of parenteral nutrition or antidiarrheic
medication at discharge. The distinction between open and
endovascular surgery was based on the primary vascular
reconstruction. As a consequence, patients undergoing lap-
arotomy with exposure of the SMA and retrograde open
mesenteric stenting12-15 of the SMA through an open
abdomen were considered part of the endovascular group.
A second-look operation was defined as a planned
control of bowel viability after endovascular or open sur-
gery. If a laparotomy was performed as an immediate
procedure in conjunction with an endovascular revascular-
ization, it was not considered a second-look, but as a part of
the primary procedure. If, however, a laparotomy was
performed later after an endovascular procedure at a de-
fined time-interval, it was considered a “second-look” pro-
cedure despite the fact that it was indeed the first laparot-
omy performed. A reoperation was defined as being
Fig 1. Incidence of open and endovascular revasculariza
from 1999 to 2006.performed for deterioration or unexpected surgical compli-cations. Completion control refers to any method used to
objectively assess the patency of the vascular reconstruction
at the end of open or endovascular surgery.
STATISTICAL ANALYSIS
All statistical analysis was performed by SPSS Statistics
v. 17.0 (SAS Institute Inc, Cary, NC). Analysis was made
according to intention-to-treat. Continuous variables were
expressed as median and interquartile range (IQR) and
analyzed using Mann-Whitney U test. Discrete variables
were analyzed with Pearson 2 test, Fisher’s exact test, or
Kendall’s Tau-b test, as appropriate. Variables associated
with 30-day and 1-year survival (P  .1) were entered into
a multivariate logistic regression analysis, and significant
associations were expressed in terms of odds ratio (OR)
with 95% confidence interval (CI). Variables associated
with long-term survival were tested in a Cox regression
analysis, and expressed in terms of hazard ratio (HR) with
95% CI. Cumulative survival was analyzed using the
Kaplan-Meier method and life table analysis. Log-rank test
was used in the overall comparison of survival curves for
open and endovascular surgery. The P values  .05 were
considered significant.
RESULTS
Time trends. The number of revascularizations in-
creased steadily to 41 interventions in 2006 as compared to
10 interventions in 1999. Endovascular approach increased
during the last 3 years of the study, with a sixfold increase in
the frequency of endovascular interventions by 2006 as
for acute superior mesenteric artery occlusion in Swedentionscompared to 1999 (Fig 1).
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(IQR 65-82), 90 women, and 71 men. The frequency of
hypertension was 42% (68 of 157), IHD 45% (72 of 159),
atrial fibrillation 52% (81 of 155), CVD 22% (36 of 161),
diabetes mellitus 13% (20 of 159), and previous vascular
surgery 24% (39 of 161). Medication with acetyl salicylic
acid and vitamin K antagonists was documented in 56% (75
of 134) and 10% (13 of 129), respectively.
Symptoms and signs. Symptoms and signs were ana-
lyzed by retrospective analysis of patient medical records,
explaining why there are missing data regarding some
variables. All 161 patients presented with abdominal pain.
The onset of symptoms was sudden in 33% (50 of 153),
acute in 44% (67 of 153), and insidious in 23% (36 of 153).
Insidious onset was associated with patient (P  .001),
doctor (P  .001), and total delay (P  .001). Vomiting,
diarrhea, and hematochezia were present in 51% (76 of
148), 53% (76 of 144), and 16% (23 of 147), respectively.
The clinical triad at presentation was denoted in 32% (45 of
139) and generalized peritonitis at presentation was present
in 5% (7 of 139). The median time from onset of symptoms
to treatment was 24 hours (IQR 10-72).
Laboratory data at admission. Median C-reactive
protein (CRP) was 30 mg/L (IQR 5-136; n  88), white
blood cell (WBC) count 14.6  109/L (IQR 11.5-20.5;
n  102), hemoglobin 140 g/L (126-151; n  98), and
creatinine 97mol/L (IQR 79-128; n 94). D-dimer was
tested in 35 patients and was elevated in all. The median
D-dimer value was 2.6 mg/L (IQR 0.9-4.3). Four patients
had a prothrombin complex value of 2.0 international
normalized ratio. A total of 25% of the patients (22 of 88)
had a CRP value of 5 mg/L and 9 patients (9%) had a
WBC count of 8.0  109/L.
Diagnosis. Documentation of the diagnostic method
was retrieved in 153 patients (95%). Diagnosis was con-
firmed after computed tomography with intravenous con-
trast (CTiv) with findings of occlusion of the SMA (n 76)
or findings of ischemic intestinal lesions (n 4). Diagnosis
was confirmed after explorative laparotomy (n  50), an-
giography (n  13), duplex ultrasound scan (n  3), and
magnetic resonance tomography with intravenous contrast
(n  1). Re-evaluation of CTiv diagnosed another 6 pa-
tients.
CTiv showed occlusion of the SMA at first evaluation in
75% (76 of 101) of the examined patients. A total of 18% of
the patients (18 of 101) that underwent a CTiv displayed
synchronous visceral emboli. An isolated embolus was dis-
lodged into the spleen, kidney, and liver in 5, 6, and 1
patient, respectively, whereas multiple visceral emboli were
detected on CT exams in 6 patients. CT scan with or
without intravenous contrast showed intestinal findings
compatible with ischemia in 34% (37 of 110). Suspicion of
intestinal ischemia in the referral letter was associated with
a diagnostic CT in 92% (48 of 52), whereas unawareness of
intestinal ischemia was associated with a low rate of positive
CT scans 37% (15 of 41; P  .001).
Treatment according to disease etiology. The fol-
lowing procedures for embolic occlusion (n  99) wereperformed: open SMA embolectomy (n  85), local SMA
thrombolysis (n  9), and endovascular aspiration SMA
embolectomy from the groin (n  3). Two failed SMA em-
bolectomies resulted in aorto-SMA bypass operations with
synthetic (n  1) and vein graft (n  1), respectively.
The following procedures for thrombotic occlusion
(n  54) were performed: antegrade stenting of the SMA
(n  18), thrombendarterectomy (n  10), aorto-SMA
bypass with synthetic (n  11) or vein graft (n  4),
retrograde open mesenteric stenting (n  4), local SMA
thrombolysis (n  4), thrombendarterectomy with a bal-
loon catheter (n  2), and reimplantation of the SMA into
the aorta (n 1).
Revascularization due to acute SMA dissection was
performed in 5 patients with the following procedures:
aorto-SMA bypass with synthetic graft (n  2), stenting
(n  1), fenestration (n  1), and embolectomy (n  1).
One patient had an acute thrombotic occlusion of a previ-
ously inserted stent within the SMA for chronic mesenteric
ischemia, which was treated with recanalization and stent-
ing. In 4 patients, the pathophysiology could not be deter-
mined. They were treated with bypass (n  1) and embo-
lectomy (n  3).
Open and endovascular surgery. The group treated
with open surgery had a higher frequency of atrial fibrilla-
tion (P  .031) and a trend toward a higher frequency of
CVD (P  .053). The group treated with endovascular
surgery had a higher frequency of history of abdominal
angina (P  .042) and a trend for a higher frequency of
previous vascular surgery (P  .09; Table I). Patients
treated by open surgery had a higher rate of embolic vs
thrombotic occlusion (P  .001), a higher frequency of
small bowel resection (P  .001), colonic resection (P 
.022), second-look operation (P  .001), and SBS (P 
.009), compared to the endovascular group (Table II). All
patients in the endovascular group underwent completion
angiographic control, whereas 34% of the patients in the
open surgery group underwent completion control with
Doppler scan (n  38) or blood flow measurement with
ultrasonic transit-time flow meter (n  3; P  .001). No
revascularization was followed by intraoperative Duplex
scan examination. Successful revascularization at primary
intervention was denoted in 86% (96 of 111) in the open
group and 79% (33 of 42) in the endovascular group,
respectively (P  .23).
Of the nine failed endovascular revascularizations,
there were five thrombolysis, three antegrade stenting, and
one aspiration embolectomy. Four endovascular revascu-
larizations were converted to open surgery; two antegrade
stenting procedures and two thrombolysis. The remaining
five were treated with additional thrombolysis. Of the 15
failed open revascularizations, there were 10 embolecto-
mies, three bypasses with autologous vein, and two throm-
bectomies. The failed revascularizations had a 30-day mor-
tality of 56% (5 of 9) in the endovascular group and 87%
(13 of 15) in the open group, respectively (P  .09).
Short-bowel syndrome. The frequency of SBS at dis-
charge was higher in the openly treated group vs the
emog
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ated with the length of small bowel (P  .001) or colonic
resection (P  .004). Five of 6 patients with stomas could
be discharged. Four patients required intravenous nutrition
at discharge due to SBS. Within 1 year, 1 patient died and
2 had their parenteral nutrition support discontinued. One
patient was still dependent on intravenous nutrition after 1
Table I. Clinical and laboratory data in patients undergoi
Open (n  12
Gender (M/F) 55/66
Age (IQR) 76 (66-81)
Comorbidities N (%)
IHD 51/118 (43
Atrial fibrillation 67/117 (57
History of abdominal angina 13/104 (12
Diabetes mellitus 15/121 (12
Smoking 25/121 (21
CVD 32/121 (26
Previous vascular surgery 24/121 (20
Symptoms
Onset of symptoms
Sudden 36/114 (32
Acute 55/114 (48
Insidious 23/114 (20
Vomiting 59/111 (53
Diarrhea 57/109 (52
Hematochezia 19/110 (17
Delay in hours Median (IQR
Patient delay (n  130) 6 (2-16)
Doctor delay (n  118) 12 (6-24)
Total delay (n  107) 24 (10-50)
Laboratory tests
CRP (mg/L; n  102) 19 (5-133)
WBC ( 109/L; n  88) 14.9 (11.5-21
Hb (g/L; n  94) 143 (126-152
Creatinine (mol/L; n  98) 101 (78-131)
CRP, C-reactive protein; CVD, cerebrovascular disease; F, female; Hb, h
SMA, superior mesenteric artery; WBC, white blood cell count.
Table II. Management-related factors, morbidity, and mo
for acute SMA occlusion
Open (n  121)
Embolus:thrombus 87:28
Management N (%)
Diagnostic CT 55/113 (49)
Laparotomy 121/121 (100)
Completion control 41/116 (35)
Small bowel resection 67/114 (59)
Colonic resection 34/114 (30)
Any bowel resection 72/115 (63)
Second-look operation 76/113 (67)
Morbidity
Reoperation 29/114 (25)
Postoperative infection 17/99 (17)
Short bowel syndrome 36/65 (55)
Mortality
30-day 51/121 (42)
1-year 71/121 (59)
CT, Computed tomography; SMA, superior mesenteric artery.year.Short-term mortality. The 30-day mortality for pa-
tients with acute thrombotic and embolic occlusion was
40% (21 of 53) and 37% (36 of 98), respectively (P .73).
Patient’s delay (P .67), doctor’s delay (P .7), and total
delay (P  .79) were not associated with 30-day mortality,
neither was second-look operation (P  .96). Age (P 
.004), hematochezia (P  .008), and insidious onset of
en vs endovascular surgery for acute SMA occlusion
Endovascular (n  42) P value
18/24 .77
77 (59-82) .50
N (%)
21/41 (51) .67
15/40 (38) .031
11/42 (26) .042
5/42 (12) .48
10/42 (24) .39
5/42 (12) .053
15/42 (36) .09
.61
14/39 (36)
12/39 (31)
13/39 (33)
17/37 (46) .59
19/37 (51) .93
4/37 (11) .57
Median (IQR)
8 (3-36) .13
24 (6-72) .16
36 (11-132) .12
46 (14-148) .29
14.0 (11.1-18.2) .76
134 (122-149) .33
92 (79-120) .49
lobin; IHD, ischemic heart disease; IQR, interquartile range; M, male;
ty in patients undergoing open vs endovascular surgery
Endovascular (n  42) P value
12:26 .001
N (%)
25/40 (62) .13
23/42 (55) .001
42/42 (100) .001
8/42 (19) .001
5/42 (12) .022
8/42 (19) .001
12/39 (31) .001
11/39 (28) .73
5/32 (16) .61
8/30 (27) .009
10/42 (24) .034
16/42 (38) .021ng op
1)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.0)
)rtaliabdominal pain (P  .012) were associated with an in-
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length of colonic resection was associated with an increased
30-day mortality (P  .097). Successful intestinal revascu-
larization at primary intervention (P .001), endovascular
surgery (P  .034), and correct diagnosis after CTiv (P 
.027) were associated with a decreased 30-day mortality
rate. When entering these seven variables into a multivari-
ate regression model, age (OR, 1.05/year; 95% CI, 1.01-
1.09; P  .012), hematochezia (OR, 4.8; 95% CI, 1.4-
16.2; P  .012), resected length of colon (OR, 1.02/cm;
95% CI, 1.01-1.04; P  .004), and insidious onset (OR,
7.1; 95% CI, 2.4-21.2.3; P  .001) remained as indepen-
dent factors associated with 30-day mortality, whereas di-
agnostic CT (OR, 2.9; 95% CI, 1.1-7.4; P  .024), suc-
cessful intestinal revascularization at primary intervention
(OR, 26.5; 95% CI, 5.9-119.1; P .001), and endovascu-
lar surgery (OR, 3.7; 95% CI, 1.2-11.6; P  .025) re-
mained as independent factors associated with improved
30-day survival. In the absence of SBS, the 30-daymortality
rate after endovascular surgery was 5% (1 of 22) compared
to 0% (0 of 29) after open surgery (P  .43).
One-year mortality. The 1-year mortality for patients
with acute thrombotic occlusion was 51% (27 of 53),
compared to those with embolic occlusion 54% (53 of
98; P  .71). The following variables were associated
with an increased 1-year mortality rate: age (P  .012),
120       50         43        34         24         17          1
41         25         23        18          9           4            
Fig 2. Kaplan-Meier analysis of long-term survival in ac
endovascular surgery (log-rank test; P  .020). Life tab
each respective time point.insidious onset (P  .019), and SBS (P  .001). Therewere trends that the length of small bowel resection (P
.061) and the length of colonic resection (P  .083)
were associated with increased 1-year mortality rates.
Successful intestinal revascularization at primary inter-
vention (P  .014) and endovascular surgery (P  .021)
were associated with an increased 1-year survival rate.
When entering these seven variables into a multivariate
regression model, only SBS (OR, 6.4; 95% CI, 1.6-24.7;
P  .007) remained as an independent factor associated
with increased 1-year mortality rate. In the absence of
SBS, the 1-year mortality rate after endovascular surgery
was 9% (2 of 22) compared to 10% (3 of 29) after open
surgery (P  .88).
Long-term survival. Long-term survival after endo-
vascular treatment for acute SMA occlusion was better than
after open surgery (P  .02; Fig 2). When the five factors
associated with outcome 1 year after operation in the
univariate analysis (P  .05) were entered in a Cox regres-
sion analysis, SBS (HR, 2.6; 95% CI, 1.3-5.0; P  .005)
and age (HR, 1.03/year; 95% CI, 1.00-1.06; P  .039)
remained as independent factors associated with decreased
long-term survival.
DISCUSSION
There has been an increase in the number of revascu-
larizations performed in Sweden for acute SMA occlusion
 8           5           4           3       OPEN 
 3           2           1           0       ENDOVASC
perior mesenteric artery occlusion comparing open and
ow patients at risk for open and endovascular surgery at2         
3          
ute su
les shduring the last 2 decades,16 especially from 2004 and
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acquisition of high-resolution multi-slice CT scanners and
an increased research activity with several publications in
this field of surgery. The dissemination of D-dimer as an
exclusion test for acute mesenteric ischemia among patients
with acute bowel symptoms22,23 may also have had an
effect. Although an elevated D-dimer lacks specificity for
acute mesenteric ischemia (many serious medical condi-
tions with activation of coagulation and fibrinolysis have
elevated D-dimer levels), this study verifies that it does
serve as an exclusion test. None of the 35 tested patients
had a normal D-dimer.
This study indicated that the delay from onset of symp-
toms to revascularization was not significantly correlated with
survival. This is probably explained by patient selection. Pa-
tients with severe symptoms are more easily diagnosed, but also
suffer from a more severe intestinal ischemia. Time delay to
intervention is important,24 but the study results imply that
revascularizationmay still be considered as a treatment option in
cases with a significant delay to surgery. This finding has been
reported previously,16 and could be explained by the rich collat-
eral mesenteric blood flow in some patients. Patients with a
verified acute SMA occlusion at a nonvascular center could ben-
efit from transport to an emergency vascular service with the
possibilityofbothopenandendovascular surgery.Suchastrategy
mightoffer ahigher chanceofproper interventionandsurvival.25
Insidious onset was, on the other hand, both associated with a
longer delay to intervention and a higher mortality rate, which
could reflect a lower diagnostic activity.
CTiv is readily available in virtually every modern sur-
gical department and was the most frequent preoperative
diagnostic method in this study. A previous study showed a
trend toward a higher rate of correct diagnosis by CT if the
referral letter included a suspicion of intestinal ischemia
and/or SMA occlusion.26 In this study, clinical suspicion in
the referral letter resulted in a higher proportion of correct
diagnosis by CTiv, and correct diagnosis after CTiv was
associated with an improved early survival rate. This is an
important observation; the clinician should guide the radi-
ologist by expressing his or her suspicion.
The endovascular group had a more favorable outcome
compared to those treated with open surgery, both in the
short-term and long-term. There were no significant differ-
ences between the two groups regarding age or gender.
The endovascular group had a higher frequency of throm-
botic occlusion and abdominal angina, whereas the group
treated with open surgery had a higher frequency of em-
bolic occlusion, atrial fibrillation, and synchronous embo-
lism. There was a trend toward a higher frequency of
previous vascular surgery in the endovascular group and
previous CVD in the group treated with open surgery.
Previous studies have reported that both thrombotic occlu-
sion2,16 and previous vascular surgery16 are factors associ-
ated with adverse outcome. The impact of disease severity
in patients receiving endovascular as opposed to open sur-
gery could only be addressed in a randomized trial. But
such a trial is unlikely to ever be performed, due to the low
frequency of SMA revascularization in most centers.Completion control by angiography was more often
performed in the endovascular group, which may have
implications on outcome. Doppler scan measurement was
used in a large proportion of patients in the open group and
this method should be considered inaccurate, whereas
blood flow measurement with ultrasonic transit-time flow
meter is more accurate, but inferior to angiography.27 No
patient in the open group underwent angiography as com-
pletion control. It must be emphasized that angiography is
superior for controlling the result after vascular interven-
tion and provides accurate imaging and flow dynamics of
the mesenteric vascular tree. Any insufficient revasculariza-
tion can be visualized and small peripheral emboli can be
detected. The information at completion control could be
considered to have prognostic implications. It seems advis-
able to validate the revascularization with angiography
whenever possible. Blood flow measurement of the main
stem of the SMA should preferably be performed in the
abdomen before and after open surgery revascularization.
In previous discussions on the advantages and short-
comings of open and endovascular therapy, the advantages
of open surgery including completion control and inspec-
tion of the bowel have been evaluated. The results of this
study imply that the better completion control of the
vascular reconstruction, being an integrated part of endo-
vascular therapy, may be equally important.
Second-look operation was more frequent in the open
group compared to the endovascular group but was not
associated with increased survival. This finding may be a
result of selection bias. Patients with the most favorable
prognosis, not experiencing any bowel symptoms after
revascularization, are not likely to undergo a second-look
procedure. This, however, is also the case for those with
poor prognosis who are not considered candidates for
further operative treatment due to advanced age or multi-
ple comorbidities. The same conclusion was made in the
previous investigation studying acute SMA occlusion in
Sweden from 1987 to 1998.16
In the multivariate Cox-regression analysis, only age and
SBS remained as independent factors associated with long-
term mortality. SBS has documented implications for surviv-
al28 and seems to be a strong negative factor for long-term
outcome in this group of patients. SBS was significantly asso-
ciated with the length of intestinal resection, as expected.
The limitations of the study are attributed to the retro-
spective analysis of the patient files, although patients were
entered prospectively in Swedvasc. It should be remem-
bered that this study includes only patients undergoing
revascularization. Patients receiving bowel resection only,
or no active treatment, are thus not included. Previous
validations of Swedvasc, based on the fact that every Swed-
ish citizen has a personal identity code used in all health care
registries, have shown that more than 90% of procedures
that are core surgery are registered.17 Revascularization of
the SMA is considered core surgery.
It remains unclear if disease severity may have accounted
for differences in outcome between the endovascular and
opengroup: comparing the extent of bowel ischemia basedon
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even in a prospective study. Most patients in the endovascular
group did not undergo laparotomy for assessment of the bowel.
If this is a result of less severe disease on presentation, or a better
outcome of treatment, remains speculative. Disease severity in
terms of CRP values at admission or time delay to intervention
didnotdifferbetween thegroups.Previous studieshave reported
that patients with thrombotic occlusion have more extensive
bowel gangrene than thosewith an embolic occlusion2,16,29 and
the endovascularly treated group had a higher proportion of
thrombotic occlusion than the open group.
Hypothetically, endovascular therapy offers many ad-
vantages over open surgery, in particular when only endo-
vascular therapy without subsequent laparotomy for evalu-
ation of the intestines is performed. It gives immediate and
complete visualization of the vascular tree before and after
intervention and the patient can be treated without the
inherent risks of general anesthesia. With the endovascular
technique, the surgical trauma can be minimized and thus
reduce infection, inflammatory response, postoperative pa-
ralysis, opioid medication, and immobilization. All of the
above could affect the clinical outcome in this group of
often elderly patients with multiple comorbidities.
In conclusion, the results after endovascular and open
surgical revascularization of acute SMA occlusion were
favorable, in particular among the endovascularly treated
patients. Group differences need to be confirmed in a
randomized trial.
This study was based on the Swedvasc Registry. Steer-
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